---
title: "Home"
url: "https://neurodex.co/"
type: "page"
published: "2025-05-21T19:26:10+00:00"
modified: "2026-10-14T18:36:49+00:00"
author: "ervin@a2z.rs"
---

## Precision Neurology

## Pioneering diagnostics using neuron-derived exosomes

## Neurodex is a biotechnology company dedicated to the development of biomarkers and diagnostic solutions for neurological disorders.

       ![](https://neurodex.co/wp-content/uploads/2026/10/Exosome-bg-faf7f8_800.jpg)

## NeuroDex Neurodiagnostic Platform

##### α-Syn

##### Biomarker

*Parkinson’s, MSA, Alzheimer’s diseases. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.

 [https://neurodex.co/alpha-synuclein-assays-alpha-syn-alpha-synuclein-%CE%B1-syn/](https://neurodex.co/alpha-synuclein-assays-alpha-syn-alpha-synuclein-%CE%B1-syn/)  [https://neurodex.co/alpha-synuclein-assays-alpha-syn-alpha-synuclein-%CE%B1-syn/](https://neurodex.co/alpha-synuclein-assays-alpha-syn-alpha-synuclein-%CE%B1-syn/)

##### TDP43

##### Biomarker

*ALS, FTD, Alzheimer's disease. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.

 [https://neurodex.co/tdp-43/](https://neurodex.co/tdp-43/)  [https://neurodex.co/tdp-43/](https://neurodex.co/tdp-43/)

##### Tau/pTau

##### Biomarker

*Alzheimer's disease. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.

 [https://neurodex.co/tau-ptau/](https://neurodex.co/tau-ptau/)  [https://neurodex.co/tau-ptau/](https://neurodex.co/tau-ptau/)

##### NF-L

##### Biomarker

*Brain injury and neuroinflammation. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.

 [https://neurodex.co/nf-l-biomarker/](https://neurodex.co/nf-l-biomarker/)  [https://neurodex.co/nf-l-biomarker/](https://neurodex.co/nf-l-biomarker/)

##### LC3

##### Biomarker

*Autophagy/lysosome across diseases. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.

 [https://neurodex.co/lc3-and-cathepsind-biomarkers/](https://neurodex.co/lc3-and-cathepsind-biomarkers/)  [https://neurodex.co/lc3-and-cathepsind-biomarkers/](https://neurodex.co/lc3-and-cathepsind-biomarkers/)

##### NF-kB

##### Biomarker

*Neuroinflammation across diseases. Monitoring biological response to treatments, pharmacodynamic, pathway engagement biomarker, and treatment response.

 [https://neurodex.co/importance-of-nf-kb-biomarker/](https://neurodex.co/importance-of-nf-kb-biomarker/)  [https://neurodex.co/importance-of-nf-kb-biomarker/](https://neurodex.co/importance-of-nf-kb-biomarker/)

##### AKT panel

##### Biomarker

*Metabolic changes like GLP1. Monitoring biological response to treatments and pharmacodynamic.

 [https://neurodex.co/akt-panel/](https://neurodex.co/akt-panel/)  [https://neurodex.co/akt-panel/](https://neurodex.co/akt-panel/)

##### Synaptic protein

##### Biomarker

*Synaptic plasticity across diseases. Monitoring biological response to treatments and pharmacodynamics.

 [https://neurodex.co/synaptic-protein/](https://neurodex.co/synaptic-protein/)  [https://neurodex.co/synaptic-protein/](https://neurodex.co/synaptic-protein/)                      [!\[https://www.yale.edu\](https://neurodex.co/wp-content/uploads/2022/10/Untitled-design-9-1.png)](https://www.yale.edu)       [!\[SBH Science\](https://neurodex.co/wp-content/uploads/2022/10/Untitled-design-11-1.png)](https://sbhsciences.com)       [!\[QurAlis\](https://neurodex.co/wp-content/uploads/2022/10/QurAlis.png)](https://www.quralis.com)       [!\[NIH\](https://neurodex.co/wp-content/uploads/2022/10/Untitled-design-10-1.png)](https://www.nih.gov)       [!\[NeuroSense\](https://neurodex.co/wp-content/uploads/2022/10/Untitled-design-2.png)](https://www.neurosense-tx.com)       [!\[MJFF\](https://neurodex.co/wp-content/uploads/2022/10/Untitled-design-6-1.png)](https://www.michaeljfox.org)                        01

Biomarker Discovery & Validation

##### Services

*Leverage brain-enriched exosomes to discover novel biomarkers for neurological diseases using immunoassays and RNA sequencing.

 [https://neurodex.co/neurodiagnostic-platform/](https://neurodex.co/neurodiagnostic-platform/)  [https://neurodex.co/neurodiagnostic-platform/](https://neurodex.co/neurodiagnostic-platform/)      02

Translational Research Biomarkers

##### Services

*Partner with pharmaceutical and biotechnology companies to translate NDE biomarkers into clinically relevant endpoints for drug development.

 [https://neurodex.co/neurological-biomarkers-research-services/pre-clinical-research-services/](https://neurodex.co/neurological-biomarkers-research-services/pre-clinical-research-services/)  [https://neurodex.co/neurological-biomarkers-research-services/pre-clinical-research-services/](https://neurodex.co/neurological-biomarkers-research-services/pre-clinical-research-services/)                      [!\[ADDF\](https://neurodex.co/wp-content/uploads/2025/05/Untitled-design-20-2.png)](https://www.alzdiscovery.org)       [!\[Stanford University\](https://neurodex.co/wp-content/uploads/2025/05/Untitled-design-14-2.png)](https://www.stanford.edu)       [!\[John Hopkins_logo\](https://neurodex.co/wp-content/uploads/2025/05/John-Hopkins_logo.png)](https://www.jhu.edu)       [!\[Alkermes\](https://neurodex.co/wp-content/uploads/2025/05/Alkermes1.png)](https://www.alkermes.com)       [!\[Trieste University\](https://neurodex.co/wp-content/uploads/2025/05/Trieste-University.png)](https://portale.units.it/it)       [!\[MGH_logo-2\](https://neurodex.co/wp-content/uploads/2025/05/MGH_logo-2.png)](https://www.massgeneral.org)                        01

Neuronal-Derived Exosome Isolation and Analysis

##### Services

   [https://neurodex.co/neurological-biomarkers-research-services/](https://neurodex.co/neurological-biomarkers-research-services/)  [https://neurodex.co/neurological-biomarkers-research-services/](https://neurodex.co/neurological-biomarkers-research-services/)      02

Clinical Trial Biomarker Support

##### Services

*Biomarker services tailored for integration into Phase I–III clinical trials. Stratification, pharmacodynamic monitoring, and endpoint analysis.

 [https://neurodex.co/neurological-biomarkers-research-services/clinical-trial-services/](https://neurodex.co/neurological-biomarkers-research-services/clinical-trial-services/)  [https://neurodex.co/research-services/clinical-trial-services/#](https://neurodex.co/research-services/clinical-trial-services/#)

## Biomarker Discovery Solutions

NeuroDex provides advanced biomarker discovery solutions that integrate seamlessly into clinical workflows. Our neuron-derived extracellular vesicle (NDE) panels enable precise disease detection, monitoring, and treatment evaluation. Validated under GLP and CLIA standards, our solutions support personalized diagnostics, enhance patient care, and optimize therapeutic strategies.

Regulatory Compliance

Clinical Trial Support

Enhanced Diagnostic Accuracy

Personalized Monitoring

                   01

#### Parkinson's disease and synucleopathy

*a-syn biomarker, novel biomarker discovery

  [view more](https://neurodex.co/α-syn/)        02

#### ALS

*TDP43 biomarker, novel biomarker discovery

  [view more](https://neurodex.co/neurodiagnostic-platform/)        03

#### Alzheimer's disease

*Tau/pTau, A-syn, biomarkers, novel biomarker discovery

  [view more](https://neurodex.co/neurodiagnostic-platform/)        04

#### Neuroinflamation

*NF-kB biomarker, novel biomarker discovery

  [view more](https://neurodex.co/neurodiagnostic-platform/)        05

#### Autophagy, Brain injury

*LC3 biomarker, novel biomarker discovery

  [view more](https://neurodex.co/neurodiagnostic-platform/)

## Biomarker Discovery Solutions

NeuroDex provides advanced biomarker discovery solutions that integrate seamlessly into clinical workflows. Our neuron-derived extracellular vesicle (NDE) panels enable precise disease detection, monitoring, and treatment evaluation. Validated under GLP and CLIA standards, our solutions support personalized diagnostics, enhance patient care, and optimize therapeutic strategies.

Personalized Monitoring

Enhanced Diagnostic Accuracy

Regulatory Compliance

Clinical Trial Support

             01

#### Parkinson's disease and synucleopathy

*a-syn biomarker, novel biomarker discovery

  [view more](https://neurodex.co/α-syn/)        02

#### ALS

*TDP43 biomarker, novel biomarker discovery

  [view more](https://neurodex.co/neurodiagnostic-platform/)        03

#### Alzheimer's disease

*Tau/pTau, A-syn, biomarkers, novel biomarker discovery

  [view more](https://neurodex.co/neurodiagnostic-platform/)        04

#### Neuroinflamation

*NF-kB biomarker, novel biomarker discovery

  [view more](https://neurodex.co/neurodiagnostic-platform/)        05

#### Autophagy, Brain injury

*LC3 biomarker, novel biomarker discovery

  [view more](https://neurodex.co/neurodiagnostic-platform/)                      [Contact us  Let's start your journey](https://neurodex.co/contact-us/) [Portfolio  Projects, developments and research](https://neurodex.co/about-us/our-projects/) [FAQ  Have a question?](https://neurodex.co/neurodex-faq/)    ![w](https://neurodex.co/wp-content/uploads/2022/10/home-2-interactive-links-1.png)   ![w](https://neurodex.co/wp-content/uploads/2022/10/home-2-interactive-links-2.png)   ![w](https://neurodex.co/wp-content/uploads/2022/10/home-2-interactive-links-3.png)